• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维拉帕米单独及联合利尿剂治疗老年原发性高血压的降压疗效

[Hypotensive efficacy of verapamil alone and in combination with a diuretic in the treatment of essential hypertension in geriatric patients].

作者信息

Latini R, Pierandrei G, Achilli L, Lombi V, D'Amico F

出版信息

G Ital Cardiol. 1987 Feb;17(2):144-8.

PMID:3301500
Abstract

To evaluate the hypotensive efficacy of Verapamil alone and combined with diuretic, in the treatment of essential hypertension in elderly patients, we studied 54 patients, mean age 67.2 +/- 4.7 years, with essential hypertension, I-II WHO class. After a two-week wash-out from previous hypotensive therapies, patients were divided, at random, into three groups and, in double-blind conditions; they were treated as follows: the first group was treated with Verapamil (V) slow-release 240 mg/die, the second group with Chlorthalidone (C) 50 mg/die and the third group with the combination of Verapamil slow-release 240 mg/die and Chlorthalidone 50 mg/die (V + C). In the first group, the therapy (V) statistically reduced (p less than 0.001) either PAS or PAD values in supine position, (respectively -13 +/- 9 mmHg and -12 +/- 4 mmHg) and PAS-PAD values in upright position (respectively -16 +/- 3 mmHg and -10 +/- 3 mmHg). In the group treated with C, a statistically significant reduction (p less than 0.001) of PAS (-12 +/- 3 mmHg in supine position and -16 +/- 3 mmHg in upright position) and of PAD (-11 +/- 5 in supine and -9 +/- 4 mmHg in upright position). In the third group, V + C treatment induced a statistically bigger reduction of PAS and PAD (p less than 0.001) than that of the other two groups either in supine (-24 +/- 3 and -21 +/- 5 mmHg, respectively) or in upright position (-26 +/- 4 and -20 +/- 5 mmHg, respectively). Three patients interrupted the therapy for scarse compliance (I-II group).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

为评估维拉帕米单用及联合利尿剂治疗老年原发性高血压的降压效果,我们研究了54例年龄平均为67.2±4.7岁的WHO I-II级原发性高血压患者。在停用先前降压治疗两周后,患者被随机分为三组,并采用双盲法进行如下治疗:第一组服用维拉帕米(V)缓释片240mg/日,第二组服用氯噻酮(C)50mg/日,第三组服用维拉帕米缓释片240mg/日联合氯噻酮50mg/日(V+C)。第一组治疗(V)使仰卧位收缩压(PAS)或舒张压(PAD)值有统计学意义地降低(p<0.001),分别降低了-13±9mmHg和-12±4mmHg,立位PAS-PAD值分别降低了-16±3mmHg和-10±3mmHg。在服用C组,PAS(仰卧位-12±3mmHg,立位-16±3mmHg)和PAD(仰卧位-11±5mmHg,立位-9±4mmHg)有统计学意义地显著降低(p<0.001)。在第三组,V+C治疗使仰卧位(分别为-24±3和-21±5mmHg)和立位(分别为-26±4和-20±5mmHg)的PAS和PAD降低幅度在统计学上比其他两组更大(p<0.001)。三名患者因依从性差中断治疗(I-II组)。(摘要截断于250字)

相似文献

1
[Hypotensive efficacy of verapamil alone and in combination with a diuretic in the treatment of essential hypertension in geriatric patients].维拉帕米单独及联合利尿剂治疗老年原发性高血压的降压疗效
G Ital Cardiol. 1987 Feb;17(2):144-8.
2
Efficacy of sustained-release verapamil: automatic ambulatory blood pressure monitoring.缓释维拉帕米的疗效:动态血压监测
J Clin Hypertens. 1986 Sep;2(3 Suppl):133S-142S.
3
[Comparison of the efficacy and tolerability of sustained-release verapamil and captopril in mild to moderate essential arterial hypertension].缓释维拉帕米与卡托普利治疗轻至中度原发性高血压的疗效及耐受性比较
Ann Cardiol Angeiol (Paris). 1991 Oct;40(8):509-13.
4
Hemodynamic effects of cadralazine or chlorthalidone in verapamil-treated elderly hypertensives.卡屈嗪或氯噻酮对维拉帕米治疗的老年高血压患者的血流动力学影响。
Int J Clin Pharmacol Ther. 1994 Apr;32(4):198-203.
5
Low-dose atenolol-chlorthalidone combination for treatment of mild hypertension.小剂量阿替洛尔-氢氯噻嗪联合用药治疗轻度高血压
Int J Clin Pharmacol Ther Toxicol. 1986 Jan;24(1):43-7.
6
Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertension.硝苯地平每日两次作为轻度原发性高血压二级治疗药物的双盲、安慰剂对照试验。
J Clin Hypertens. 1987 Dec;3(4):579-88.
7
Efficacy and tolerability of enalapril and sustained-release verapamil in older patients with mild to moderate essential hypertension.依那普利与缓释维拉帕米治疗老年轻至中度原发性高血压的疗效及耐受性
Clin Ther. 1990 Mar-Apr;12(2):139-48.
8
Antihypertensive effects of verapamil, captopril and their combination at rest and during dynamic exercise.维拉帕米、卡托普利及其联合用药在静息和动态运动时的降压作用。
Arzneimittelforschung. 1992 Feb;42(2):103-7.
9
Antihypertensive efficacy of sustained-release verapamil.缓释维拉帕米的降压疗效
J Clin Hypertens. 1987 Dec;3(4):536-46.
10
Combined terazosin and verapamil therapy in essential hypertension. Hemodynamic and pharmacokinetic interactions.特拉唑嗪与维拉帕米联合治疗原发性高血压。血流动力学及药代动力学相互作用。
Am J Hypertens. 1995 Feb;8(2):133-45. doi: 10.1016/0895-7061(94)00162-5.

引用本文的文献

1
Racial differences in antihypertensive therapy: evidence and implications.抗高血压治疗中的种族差异:证据与启示
Cardiovasc Drugs Ther. 1990 Mar;4 Suppl 2:379-82. doi: 10.1007/BF02603180.